Hans Salwender
- Hematology top 1%
- Molecular Biology
- Oncology top 5%
- Epidemiology top 10%
- Public Health, Environmental and Occupational Health top 10%
- Co-authors
- Hartmut GoldschmidtDieter BuchheidtGerlinde EgererE. MiltnerKenshi SuzukiJeremy A. RossBirte FriedrichsMarkus Tiemann
- Topics
- Multiple Myeloma Research and Treatments (41 papers)Protein Degradation and Inhibitors (25 papers)Cancer Treatment and Pharmacology (13 papers)
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaBlood
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Hans Salwender
57 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 100
- Hematology 862
- Molecular Biology 650
- Oncology 617
- Epidemiology 254
- Public Health, Environmental and Occupational Health 245
Countries citing papers authored by Hans Salwender
This map shows the geographic impact of Hans Salwender's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans Salwender with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans Salwender more than expected).
Fields of papers citing papers by Hans Salwender
This network shows the impact of papers produced by Hans Salwender. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans Salwender. The network helps show where Hans Salwender may publish in the future.
Co-authorship network of co-authors of Hans Salwender
This figure shows the co-authorship network connecting the top 25 collaborators of Hans Salwender. A scholar is included among the top collaborators of Hans Salwender based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans Salwender. Hans Salwender is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 2 | |
| 4 | 3 | |
| 5 | 20 | |
| 6 | 7 | |
| 7 | 4 | |
| 8 | 7 | |
| 9 | 20 | |
| 10 | 28 | |
| 11 | 6 | |
| 12 | 62 | |
| 13 | 40 | |
| 14 | 62 | |
| 15 | 30 | |
| 16 | 48 | |
| 17 | 56 | |
| 18 | 5 | |
| 19 | 11 | |
| 20 | 26 |
About Hans Salwender
Hans Salwender is a scholar working on Hematology, Emergency Medical Services and Oncology, having authored 66 papers that have together received 1.7k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (41 papers), Protein Degradation and Inhibitors (25 papers) and Cancer Treatment and Pharmacology (13 papers). The work is most often cited by research in Hematology (862 citations), Emergency Medical Services (233 citations) and Oncology (617 citations). Hans Salwender has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Hartmut Goldschmidt, Dieter Buchheidt, Gerlinde Egerer, E. Miltner, Kenshi Suzuki, Jeremy A. Ross, Birte Friedrichs, Markus Tiemann, Karl Verpoort and Philippe Moreau. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.